FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Denies Petition on Eugia Pharma ANDA

[ Price : $8.95]

FDA denies a petition questioning Eugia Pharmas use of an ANDA for a generic Makena autoinjector.

Improve Cancer Checkpoint Inhibitor Development: Pazdur

[ Price : $8.95]

Oncology Center of Excellence director Richard Pazdur and chief of medical oncology Julia Beaver call for changes in the developme...

FTC Should Look Into Par Vasostrict Petition: FDA

[ Price : $8.95]

FDA denies a Par Sterile Products petition saying it failed to raise valid scientific or regulatory issues and was submitted as a ...

Guide on Inspecting Injectables for Particulates

[ Price : $8.95]

FDA posts a draft guidance entitled Inspection of Injectable Products for Visible Particulates.

Proposed Rule on QSR Harmonization Soon: Maisel

[ Price : $8.95]

CDRH Office of Product Evaluation and Quality director William H. Maisel tells an industry conference that the agency is planning ...

Drug, Device Violations in Dental Technologies Inspection

[ Price : $8.95]

FDA warns Lincolnwood, IL-based Dental Technologies about CGMP and QS regulation violations at its contract drug and medical devic...

FDA Revises Janssen Covid Vaccine Fact Sheets

[ Price : $8.95]

FDA says fact sheets for the Janssen Covid-19 vaccine have been updated with a Contraindication for the vaccine in individuals wit...

Device Definition Draft Guidance

[ Price : $8.95]

FDA issues a draft guidance on the redesignation of the definition of device in the Federal Food, Drug, and Cosmetic Act and the a...

Abdominal Pain Nerve Stimulator is Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies the nonimplanted nerve stimulator for functional abdominal pain relief into Class 2 (speci...

Endoscopic Transhepatic Venous Needle is Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies the endoscopic transhepatic venous access needle into Class 2 (special controls).